Effect of interferon-γ and tumor necrosis factor-α on hepatitis B virus following lamivudine treatment

Figure 3 Lamivudine pretreatment significantly reduces interferon-γ + tumor necrosis factor-α-mediated toxicity of HepG2. 2.15 cells. Percent cell survival was analyzed with the cell counting kit (CCK)-8 assay following exposure of HepG2.2.15 cells to the four treatments. Data are expressed as the mean ± SD from three individual experiments. ^aP < 0.05 vs control, ^cP < 0.05 vs lamivudine group, ^eP < 0.05 vs cytokine group.